Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.

[1]  A. K. Chao,et al.  Fusion driven JMML: a novel CCDC88C–FLT3 fusion responsive to sorafenib identified by RNA sequencing , 2019, Leukemia.

[2]  J. Tyner,et al.  Two myeloid leukemia cases with rare FLT3 fusions , 2018, Cold Spring Harbor molecular case studies.

[3]  K. Roskin,et al.  A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia. , 2017, Cancer genetics.

[4]  W. Tapper,et al.  Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia , 2017, Leukemia.

[5]  Depei Wu,et al.  Multiple MYO18A-PDGFRB fusion transcripts in a myeloproliferative neoplasm patient with t(5;17)(q32;q11) , 2017, Molecular Cytogenetics.

[6]  C. Bloomfield,et al.  High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  B. Petit,et al.  A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3? , 2016, Leukemia.

[8]  R. Luthra,et al.  ETV6–FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant , 2014, Leukemia.

[9]  A. Porwit,et al.  ETV6/FLT3 fusion in a mixed-phenotype acute leukemia arising in lymph nodes in a patient with myeloproliferative neoplasm with eosinophilia , 2014, Journal of Hematopathology.

[10]  K. Chonabayashi,et al.  Successful allogeneic stem cell transplantation with long-term remission of ETV6/FLT3-positive myeloid/lymphoid neoplasm with eosinophilia , 2014, Annals of Hematology.

[11]  E. De Braekeleer,et al.  ETV6 fusion genes in hematological malignancies: a review. , 2012, Leukemia research.

[12]  R. Marschalek,et al.  A three-way translocation of MLL, MLLT11, and the novel reciprocal partner gene MYO18A in a child with acute myeloid leukemia. , 2012, Cancer genetics.

[13]  T. Haferlach,et al.  Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3. , 2011, Blood.

[14]  N. Russell,et al.  A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy. , 2007, Experimental hematology.

[15]  Y. Sakaki,et al.  FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation , 2006, Leukemia.

[16]  M. Tanimoto,et al.  Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution. , 1997, Blood.

[17]  M. Tanimoto,et al.  Acute myeloblastic leukemia (M2) with translocation (7;11) followed by marked eosinophilia and additional abnormalities of chromosome 5. , 1995, Cancer genetics and cytogenetics.

[18]  I. L. Polyatskin,et al.  [Revised WHO classification of tumors of hematopoietic and lymphoid tissues, 2017 (4th edition):lymphoid tumors]. , 2019, Arkhiv patologii.